RecruitingType 2 Diabetes Treated With InsulinPregnancy, High Risk
Continuous Glucose Monitor Use in Pregnancy
Eligible age
18+ yrs
Accepts
Women
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this study is to perform a randomized controlled trial among 180 pregnant women with type 2 diabetes mellitus (T2DM) comparing continuous glucose monitor (CGM) use to the standard of care of multiple daily fingerstick glucose monitoring and its impact on large for gestational age infants, maternal glycemic control, patient satisfaction, and additional adverse perinatal outcomes.
Sponsor: University of Massachusetts, Worcester
You may qualify if…
- ✓ 1\) age greater than or equal to 18 years old
- ✓ 2\) singleton gestation less than or equal to 14 weeks at initial obstetric visit
- ✓ 3\) established diagnosis of T2DM by laboratory criteria including hemoglobin A1c ≥6.5%, oral glucose tolerance test ≥200 mg/dL, or fasting plasma glucose ≥126 mg/dL
- ✓ 4\) receiving prenatal care at UMASS Memorial Health Care (UMMHC) and plans to deliver at UMMHC
- ✓ 5\) able and willing to provide informed consent
You may not qualify if…
- ✕ 1\) known diagnosis of type 1 diabetes or gestational diabetes
- ✕ 2\) plan to receive prenatal care or delivery outside of UMMHC
- ✕ 3\) inability to provide informed consent
- ✕ 4\) multifetal gestation
Where it's recruiting
Massachusetts
Worcester
Source: ClinicalTrials.gov · NCT05317585 · last updated 2026-08-03